Flomics updates its COVID-19 NGS data analysis cloud platform – #BHHMembersInitiatives

BHH member Flomics Biotech, a startup operating in the genomics and liquid biopsy fields and mainly dedicated to the early diagnosis of cancer, continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of –FlomicsCOVID19– a cloud-based Next Generation Sequencing (NGS) platform for fast and automated analysis of.

#BHHMembersInitiatives to fight against #Covid19 – Flomics

Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for Covid-19 detection and research. Combining the unique features of the different experimental sequencing kits available for SARS-CoV-2 detection (either metagenomics or amplicon based), Flomics maximizes the information extracted from each single experiment performed.